Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.24 USD | +0.20% | 0.00% | -37.63% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 526M | Capitalization | 1.07B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -28M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
-28.5
x | P/E ratio 2025 * |
-36.5
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.79% |
Latest transcript on AtriCure, Inc.
1 day | +0.02% | ||
Current month | -1.24% | ||
1 month | +0.72% | ||
3 months | -41.05% | ||
6 months | -32.53% | ||
Current year | -37.63% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 430 M€ | -.--% | ||
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 22.35 | +0.68% | 38 494 |
24-06-05 | 22.2 | -1.38% | 554,564 |
24-06-04 | 22.51 | +0.40% | 479,660 |
24-06-03 | 22.42 | -0.53% | 589,317 |
24-05-31 | 22.54 | +1.26% | 704,126 |
Delayed Quote Nasdaq, June 06, 2024 at 10:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.63% | 1.07B | |
-4.67% | 180B | |
+0.69% | 108B | |
-2.23% | 68.29B | |
-6.73% | 46.96B | |
+14.14% | 45.64B | |
+7.77% | 42.41B | |
+20.02% | 31.01B | |
+16.55% | 25.51B | |
-6.60% | 23.17B |
- Stock Market
- Equities
- ATRC Stock